Sunday, June 20, 2021

The cardiomyopathy of Friedreich's ataxia common in a family: A case report

›
Amini O, Lakziyan R, Abavisani M, Sarchahi Z. Ann Med Surg (Lond). 2021 May 24;66:102408. doi: 10.1016/j.amsu.2021.102408.  Because early di...
Thursday, June 17, 2021

New biotech kid on the block making news

›
June 17, 2021. Capsida Biotherapeutics, a Newbury Park-based startup that recently raised $140 million in Series A funding, is partnering wi...

Inicio Ronda de Inversión Biointaxis con Capital Cell

›
06.17.2021. Biointaxis es una spin-off biotecnológica surgida del Instituto de Investigación Germans Trias i Pujol (IGTP) y del grupo farmac...
Wednesday, June 16, 2021

CRISPR Therapeutics and Capsida Biotherapeutics Announce Strategic Collaboration to Develop Gene-Edited Therapies for Amyotrophic Lateral Sclerosis and Friedreich’s Ataxia

›
ZUG, Switzerland and CAMBRIDGE, Mass. and THOUSAND OAKS, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a bio...
Tuesday, June 15, 2021

A pathogenic role for histone H3 copper reductase activity in a yeast model of Friedreich's Ataxia

›
Oscar A Campos, Narsis Attar, Nathan V Mallipeddi, Chen Cheng, Maria Vogelauer, Stefan Schmollinger, Sabeeha S Merchant, Siavash K Kurdistan...
Monday, June 14, 2021

Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA) (ARTEMIS)

›
ClinicalTrials.gov Identifier: NCT04921930; Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Collaborator: Imagine...
Saturday, June 12, 2021

Automatic speech recognition in neurodegenerative disease

›
Authors: Benjamin G. Schultz, Venkata S. Aditya Tarigoppula, Gustavo Noffs, Sandra Rojas, Anneke van der Walt, David B. Grayden, Adam P. Vog...
Thursday, June 10, 2021

Blindness and Deafness – an Extreme Phenotype in Friedreich Ataxia

›
Joana Damásio, Ana Sardoeira, Maria Araújo, Isabel Carvalho, Jorge Sequeiros, José Barros; Research Square; 2021. DOI: 10.21203/rs.3.rs-5730...
Tuesday, June 8, 2021

Luz verde a un ensayo clínico con calcitriol para validar su potencial terapéutico para tratar la Ataxia de Friedreich

›
Comunicación y Prensa IRBLleida; Lunes, 7 de junio de 2021 Un ensayo clínico podría validar el uso del calcitriol, la forma activa de la vit...

A clinical trial with calcitriol has begun to validate its therapeutic potential for treating Friedreich's Ataxia

›
Biotech-spain.com; 07/06/2021  A clinical trial could validate the use of calcitriol, the active form of vitamin D, to treat Friedreich'...